Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2015-03-24 Regulatory Filings
Country SE Sweden
Listing ST PROB

About Probi

https://www.probi.com/

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Probi AB and Wageningen University enter long-term research collaboration
Regulatory Filings Classification · 1% confidence The document is a press release announcing a long-term research collaboration between Probi AB and Wageningen University regarding probiotic bacteria mechanisms. This type of announcement, detailing strategic partnerships, research agreements, or general corporate news that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV), typically falls under general regulatory announcements or miscellaneous corporate news. Since it is not a formal financial report, a management change, a director's dealing, or a specific financing event, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for significant, non-standard corporate disclosures required by market regulations (as indicated by the closing statement referencing Swedish Securities Market Act). The document length is short (3753 chars), but it is the primary announcement itself, not an announcement *of* another report, so RPA is not the best fit.
2015-03-24 English
Probi AB och Wageningen University tillkännager långsiktigt forskningssamarbete
Regulatory Filings Classification · 1% confidence The document is a 'PRESSMEDDELANDE' (Press Release) announcing a four-year research collaboration between Probi AB and Wageningen University regarding the anti-inflammatory mechanisms of probiotics. This type of announcement, detailing strategic partnerships, research developments, or general corporate news that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report (like 10-K or IR), nor a specific management change (MANG) or capital event (CAP), the most appropriate general category for a non-standard regulatory announcement is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous official disclosures. The document length is short (3687 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA is less fitting than RNS for this type of strategic news.
2015-03-24 Swedish
Probi Digestis® lanseras på nya asiatiska marknader
Regulatory Filings Classification · 1% confidence The document is a press release (PRESSMEDDELANDE) announcing a new multi-year agreement between Probi AB and DKSH for the launch and marketing of Probi Digestis® in Hong Kong and Macau. It details a business expansion and partnership, including management commentary and contact information. This type of announcement, which details strategic business developments, partnerships, or expansion plans, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA, POS). It is a general corporate announcement. Since it is not a standard regulatory filing like a 10-K or a specific report like an AR or CT, and it is not explicitly announcing the publication of a major report (which would suggest RPA), the most appropriate fallback category is Regulatory Filings (RNS) for general corporate news that must be disclosed.
2015-03-03 Swedish
Probi Digestis® to be launched on new markets in Asia
Regulatory Filings Classification · 1% confidence The document is titled "PRESS RELEASE" and announces a business development agreement between Probi AB and DKSH for launching a product in new Asian markets. It contains forward-looking statements, business updates, and contact information typical of a corporate announcement. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER) focusing on financial figures, or a proxy statement (DEF 14A). Since it is a general, material business announcement that doesn't fit the specific categories like M&A (TAR) or Capital Change (CAP), it falls best under the general Regulatory Filings category (RNS), which serves as a fallback for miscellaneous regulatory disclosures, especially since it explicitly states the information is submitted for disclosure under Swedish securities law.
2015-03-03 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-end Report) for Probi AB for the fiscal year 2014. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed management commentary on business performance, market trends, and future outlook. As it provides substantive financial data for a period shorter than a full annual report (covering Q4 and the full year 2014) and is not merely an announcement or certification, it fits the definition of an Interim/Quarterly Report. FY 2014
2015-01-28 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is titled 'PROBI AB 2014 YEAR-END REPORT' and contains comprehensive financial statements, including net sales, operating profit, cash flow, and earnings per share for both the fourth quarter and the full fiscal year 2014. It also includes detailed management commentary, operational updates, and financial tables. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year (the fourth quarter) and the full year, it qualifies as an Interim/Quarterly Report. FY 2014
2015-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.